Evidence map›Paper›PMID 30333170›Full record

ArticleJournal of virology2019

Multiple Introductions and Antigenic Mismatch with Vaccines May Contribute to Increased Predominance of G12P[8] Rotaviruses in the United States.

Kristen M Ogden, Yi Tan, Asmik Akopov, Laura S Stewart, Rendie McHenry, Christopher J Fonnesbeck, Bhinnata Piya, Maximilian H Carter, Nadia B Fedorova, Rebecca A Halpin and 9 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 4 institutions in 1 country.

Kristen M OgdenDepartment of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA kristen.ogden@vanderbilt.edu suman.r.das@vanderbilt.edu.
Yi TanDepartment of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Asmik AkopovJ. Craig Venter Institute, Rockville, Maryland, USA.
Laura S StewartDepartment of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Rendie McHenryDepartment of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Christopher J FonnesbeckDepartment of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Bhinnata PiyaDepartment of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Maximilian H CarterDepartment of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Nadia B FedorovaJ. Craig Venter Institute, Rockville, Maryland, USA.
Rebecca A HalpinJ. Craig Venter Institute, Rockville, Maryland, USA.
Meghan H ShiltsDepartment of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Kathryn M EdwardsDepartment of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Daniel C PayneCenters for Disease Control and Prevention, Atlanta, Georgia, USA.
Mathew D EsonaCenters for Disease Control and Prevention, Atlanta, Georgia, USA.
Slavica Mijatovic-RustempasicCenters for Disease Control and Prevention, Atlanta, Georgia, USA.
James D ChappellDepartment of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
John T PattonLaboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.ORCID 0000-0003-1572-0732
Natasha B HalasaDepartment of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Suman R DasDepartment of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA kristen.ogden@vanderbilt.edu suman.r.das@vanderbilt.edu.ORCID 0000-0003-2496-9724
Vanderbilt University Medical Center · USJ. Craig Venter Institute · USCenters for Disease Control and Prevention · USNational Institutes of Health · US

Funding

The Vanderbilt Institute for Clinical and Translational Research (VICTR)UL1TR000445 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BERNARD, GORDON RAPHAEL · 2012 to 2016
$41.4M
Viral and Host Determinants of Infant and Childhood Allergy and AsthmaU19AI095227 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Dawn C Newcomb · 2011 to 2026
$34.9M
Translational Analysis CoreP30DK058404 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RICHARD M. PEEK · 2002 to 2026
$29.9M
The J. Craig Venter Institute Genome Center for Infectious DiseasesU19AI110819 · NIAID · J. CRAIG VENTER INSTITUTE, INC. · PI NELSON, KAREN E., NIERMAN, WILLIAM CHARLES · 2014 to 2018
$29.7M
Tennessee CFAR: Implementation of Culturally Responsive Trauma-Informed Care with Youth with HIV in Memphis, TNP30AI110527 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Stephany Norah Duda · 2015 to 2026
$27.5M
Resource for Biocomputing Visualization and InformaticsP41GM103311 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FERRIN, THOMAS E · 2012 to 2017
$8.2M
Enhanced Surveillance for New Vaccine Preventable DiseasesU01IP001063 · IP · VANDERBILT UNIVERSITY MEDICAL CENTER · PI HALASA, NATASHA BASSAM · 2016 to 2020
$6.3M
NEW VACCINE SURVEILLANCE NETWORK -Patient Protection-ACAU01IP000464 · IP · VANDERBILT UNIVERSITY · PI HALASA, NATASHA BASSAM · 2011 to 2015
$3.5M
ACL HHS U01IP000464NCATS NIH HHS UL1 TR000445NCIRD CDC HHS K01 IP000163NCIRD CDC HHS U01 IP000464NCIRD CDC HHS U01 IP001059NCIRD CDC HHS U01 IP001063NIAID NIH HHS P30 AI110527NIAID NIH HHS U19 AI095227NIAID NIH HHS U19 AI110819NIDDK NIH HHS P30 DK058404NIGMS NIH HHS P41 GM103311
6 · The paper itself

Abstract

Rotavirus is the leading global cause of diarrheal mortality for unvaccinated children under 5 years of age. The outer capsid of rotavirus virions consists of VP7 and VP4 proteins, which determine viral G and P types, respectively, and are primary targets of neutralizing antibodies. Successful vaccination depends upon generating broadly protective immune responses following exposure to rotaviruses presenting a limited number of G- and P-type antigens. Vaccine introduction resulted in decreased rotavirus disease burden but also coincided with the emergence of uncommon G and P genotypes, including G12. To gain insight into the recent predominance of G12P[8] rotaviruses in the United States, we evaluated 142 complete rotavirus genome sequences and metadata from 151 clinical specimens collected in Nashville, TN, from 2011 to 2013 through the New Vaccine Surveillance Network. Circulating G12P[8] strains were found to share many segments with other locally circulating strains but to have distinct constellations. Phylogenetic analyses of G12 sequences and their geographic sources provided evidence for multiple separate introductions of G12 segments into Nashville, TN. Antigenic epitopes of VP7 proteins of G12P[8] strains circulating in Nashville, TN, differ markedly from those of vaccine strains. Fully vaccinated children were found to be infected with G12P[8] strains more frequently than with other rotavirus genotypes. Multiple introductions and significant antigenic mismatch may in part explain the recent predominance of G12P[8] strains in the United States and emphasize the need for continued monitoring of rotavirus vaccine efficacy against emerging rotavirus genotypes.

Indexed as

Antigens, ViralCapsid ProteinsChild, PreschoolGenotyping TechniquesHumansInfantPhylogenyPopulation SurveillanceRotavirusRotavirus InfectionsRotavirus VaccinesSequence Analysis, RNAUnited StatesAntigens, ViralCapsid ProteinsRotavirus VaccinesVP7 protein, RotavirusefficacyG12P[8]genotypephylogeneticsrotavirusvaccine

Identifiers

PMID30333170
PMCPMC6288334
OpenAlexW2896526496

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.